Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials | Global Health | JAMA

This interim analysis of 2 randomized trials compares adverse reactions and neutralizing antibody responses to inactivated coronavirus disease 2019 (COVID-19) v

Related Keywords

Beijing ,China ,Huazhong ,Hubei ,Qiaokou ,Jiangxi ,Wuhan ,Tongji ,Sichuan ,Jinyintan ,Qinghai ,Henan ,Wuzhi ,Chaoyang ,Liaoning ,Chinese ,Xuqin Yang ,Yunkai Yang ,Yanbo Zhang ,Yuntao Zhang ,Xiaoming Yang ,Yongli Yang ,China National Biotec Group Co Ltd ,School Of Public Health ,Henan Provincial Center ,National Medical Products Administration Of China ,Ministry Of Science ,National Institutes For Food ,Technology Of The People Republic China ,National Genomic Data Center ,China National Biotec Group Company ,Huazhong University Of Science ,Chinese Academy Of Science ,Wuhan Institute Of Biological Products Co Ltd ,Tongji Medical College ,Henan Province ,Wuhan Institute ,Biological Products Co Ltd ,Disease Control ,Henan Provincial ,Wuzhi Country ,Chinese Academy ,Jinyintan Hospital ,National Institutes ,Drug Control ,National Medical Products Administration ,Chinese Clinical Trial Registry ,Middle East ,China National Biotec Group Company Limited ,Chaoyang District ,Public Health ,Huazhong University ,Qiaokou District ,Drs Duan ,Interest Disclosures ,National Program ,Key Research Project ,Major Science ,Technology Project ,National New Drug Development ,